<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20241013063348N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-12-04</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Studying the effect of Kyphologic and Maria Adelaide Orthoses on the Sagittal Spinal Curves</public_title>
      <acronym></acronym>
      <scientific_title>Studying the effect of Kyphologic and Maria Adelaide Orthoses on the Sagittal Spinal Curves in people with Scheuermann’s Kyphosis: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-12-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>10</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/79600</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In order to control the confounding variables, the samples are randomly divided into two equal groups using the kyphological orthosis and the Maria Adelaide orthosis users. In random allocation, the size of each block is considered to be four people. The test group includes the users of kyphological orthosis and is marked with the letter N. The control group includes users of the Maria Adelaide orthosis and is marked with the letter O. Considering the two test and control groups, the number of 6 blocks is obtained. The arrangement of the members of each block will be (NNOO), (NOON), (NONO), (OONN), (ONNO) and (ONON). Then these 6 modes are written separately on the paper and poured into a container. With two draws, the number of four sample people for each group and eight people in total are selected. To choose the other two, we continue the lottery until one of the blocks (NOON), (NONO), (ONNO) or (ONON) comes out of the lottery.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Scheuermann’s Kyphosis.</hc_freetext>
      <i_freetext>Intervention 1: Test group: Kyphologic Orthosis، It is a thermoplastic TLSO orthosis that extends anteriorly from the cavity of the Coracoid appendage to the symphysis pubis and posteriorly from the apex of the thoracic arch to the sacrum bone. This belt opens from the front and does not cover the areas of the gluteal muscles. Intervention 2: Control group: Adelaide Orthosis، A thermoplastic TLSO orthosis  that has a pelvic girdle. This pelvic girdle extends anteriorly from the xiphoid process to the pubic region, and posteriorly, the posterior longitudinal pads extend from the hip region to the thoracic kyphosis region. The pelvic belt opens from the back. In the anterior part of the brace, there is a sternal pad in the area below the supra sternal incision, and this pad is connected to the pelvic belt by two side metal bars.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Study information other than individual information is shared with other researchers.

When:
Information will be shared after results or data summaries are shared.

To whom:
Information is shared for academic purposes only.

Conditions:
Information is shared for the research and teaching of applicants.

Where to obtain:
People can get the information from the  responsible person.

How to obtain:
Applications must be sent via email.  (sadeghi@rehab.mui.ac.ir)

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Ebrahim Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jarib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 5096</telephone>
        <email>sadeghi@rehab.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Ebrahim Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jarib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 5096</telephone>
        <email>sadeghi@rehab.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The kyphosis angle of the thoracic or thoracolumbar region is more than 45 degrees
Risser sign is between zero and two
The apex of the arch is at T7 or lower
There should be no prohibition to use an orthosis</inclusion_criteria>
      <agemin>8 years</agemin>
      <agemax>16 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The kyphosis angle of the thoracic region should be more than 75 degrees
In addition to kyphosis, have scoliosis
have musculoskeletal, neurological or metabolic diseases at the same time
BMI is more than 30
Deformity of the spine is congenital
Have a history of spine surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Test group: Kyphologic Orthosis، It is a thermoplastic TLSO orthosis that extends anteriorly from the cavity of the Coracoid appendage to the symphysis pubis and posteriorly from the apex of the thoracic arch to the sacrum bone. This belt opens from the front and does not cover the areas of the gluteal muscles</i_keyword>
      <i_keyword>Control group: Adelaide Orthosis، A thermoplastic TLSO orthosis  that has a pelvic girdle. This pelvic girdle extends anteriorly from the xiphoid process to the pubic region, and posteriorly, the posterior longitudinal pads extend from the hip region to the thoracic kyphosis region. The pelvic belt opens from the back. In the anterior part of the brace, there is a sternal pad in the area below the supra sternal incision, and this pad is connected to the pelvic belt by two side metal bars.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Cervical Lordosis Angle. Timepoint: Before, one month and six months after the intervention. Method of measurement: EOS radiography device operator software.</prim_outcome>
      <prim_outcome>Thoracic Kyphosis Angle. Timepoint: Before, one month and six months after the intervention. Method of measurement: EOS radiography device operator software.</prim_outcome>
      <prim_outcome>Lumbar Lordosis Angle. Timepoint: Before, one month and six months after the intervention. Method of measurement: EOS radiography device operator software.</prim_outcome>
      <prim_outcome>Sagittal Vertical Axis. Timepoint: Before, one month and six months after the intervention. Method of measurement: EOS radiography device operator software.</prim_outcome>
      <prim_outcome>Sacral Inclination Angle. Timepoint: Before, one month and six months after the intervention. Method of measurement: EOS radiography device operator software.</prim_outcome>
      <prim_outcome>Pelvic Tilt Angle. Timepoint: Before, one month and six months after the intervention. Method of measurement: EOS radiography device operator software.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Satisfaction score. Timepoint: Six months after the intervention. Method of measurement: Questionnaire survey of orthosis and prosthesis users.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-10-07</approval_date>
        <contact_name>Ethics Committee of Faculty of Nursing, Management and Rehabilitation - Isfahan University of Medica</contact_name>
        <contact_address>Hezar jarib Ave Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
